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Abstract
Amyloidosis is a rare disease characterised by the deposition of insoluble extracellular fibrillar
proteins in various tissues of the body. The pattern of manifestation is organ dependent and also
on whether the disease is localised or systemic, primary or secondary.
Though the disease is usually fatal with a 5-year survival rate of 20%, there is still paucity of
literature on this disease entity worldwide. Diagnosis has remained mostly at autopsy.
A case of amyloid angiopathy involving the submandibular gland and floor of the mouth with an
associated fatal bleed is reported. The purpose of this case report is to reiterate the importance
of a high index of suspicion in the approach to the management of head and neck swellings.
Introduction
Amyloidosis is a rare disease characterised by the deposi-
tion of an insoluble extracellular fibrillar protein in vari-
ous tissues of the body. It can be primary systemic,
secondary systemic, localised, myeloma-associated or
hereditary-familial. These categories constitute 56%, 8%,
9%, 26% and 1% respectively [1]. The primary systemic
form affects mainly mesenchymal tissues such as the
heart, tongue, and gastro-intestinal tract (GIT). The sec-
ondary form is however associated with destructive
chronic inflammatory diseases such as tuberculosis, lep-
rosy, rheumathoid arthritis, ankylosing spondylitis and
osteomyelitis. This form affects primarily the kidneys,
adrenals, liver and spleen. About 12% of myeloma
patients develop amyloidosis [2].
All types of amyloidosis consist of a major fibrillar protein
derived from a precursor protein through conversion by
cells suspected to be macrophages, though yet to be con-
firmed. These proteins define the type of amyloid in 95%
of cases. In addition there are the minor fibrillar proteins
that include a P-component derived from Serum Amyloid
P-component (SAP), apolipoprotein E(apoE), heparan
sulphate proteoglycan, glycosaminoglycans and some
other glycoproteins which constitute the remaining 5%.
About 20 different fibrils have been described in human
amyloidosis, each with a different clinical picture.
The disease has been called different names by various
authors including paramyloidosis, malignant amyloido-
sis, essential amyloidosis, Wilds disease, Wild-Lubarschs
disease, systemic amyloidosis, and generalised amyloido-
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ing the disease [3,4].
Literature on amyloid angiopathy globally is scanty and
specific literature on the involvement of the submandibu-
lar salivary gland and the floor of the mouth is even rarer.
It is the purpose of this communication to report a case of
amyloid angiopathy involving the submandibular sali-
vary gland and the floor of the mouth, the first report of
its kind from the West African Sub-region. The problems
with diagnosis and management are highlighted.
Case presentation
A 56 year old retired male civil servant who had been
referred from the surgical outpatient department with a
Fine Needle Aspiration Cytology (FNAC) report of benign
salivary gland tumour, presented to our ENT department
in the same institution, with a one year history of gradual
but progressive bilateral swellings of the submandibular
region. There was no associated variation in size with
feeding. It was initially painless but the patient had devel-
oped some burning sensation involving the head and
neck region. There were no associated purulent discharge,
halitosis, dryness in or of the mouth or eyes and no upper
lid swelling. About the same time, he noticed progressive
tongue enlargement that almost filled the oral cavity and
resulted in affectation of his speech. There were no other
laryngologic, rhinologic or otologic symptoms. His appe-
tite was good with no weight loss or abdominal discom-
fort. He had no symptoms referable to the
musculoskeletal system.
Physical examination revealed an anxious ill-looking
middle-aged man with an open mouth posture and" hot
potato" speech. In addition, he had thickened skin of the
head and neck region and massive macroglossia obscur-
ing the visualization of the oropharynx. The tongue
appeared depapillated but moist and pink. There was
bilateral submandibular salivary gland enlargement, each
measuring 4 by 3 cm, bosselated, firm to hard in consist-
ency and attached to skin. There was no lacrimal gland
swelling or slanting of the palpebral fissures.
A provisional diagnosis of Multiple Myeloma with Amy-
loidosis was made with Mikulicz disease as differential
diagnosis.
Investigations done included: Full blood count with PCV-
38%, WBC-6,400/cmm; neutrophil-42% (low), lym-
phocytes-46% (slightly above normal), monocytes-7%
(normal), platelets-123,000/cmm (low). Electrolytes,
Urea and Creatinine were within normal limits while uri-
nalysis, was normal. HIV 1 and 2 screening by the rapid
kit method was non-reactive. An Ultrasound scan (USS)
of the neck revealed a normal thyroid gland and diffuse
enlargement of the submandibular glands devoid of
stones, cysts, or lymph node enlargement.
He had an open biopsy of the submandibular gland in
which a 2.0 by 0.5 centimeter wedge biopsy was taken
from the left submandibular gland. This provoked a tor-
rential bleed giving the impression of a major arterial
injury but careful search revealed no identifiable blood
vessel and the idea of external carotid artery ligation was
jettisoned after having finally secured haemostasis by
mass suturing (tissue was friable). Pressure dressing was
also applied. About 250–500 mls of blood was lost and
patient was subsequently admitted for observation.
He was discharged after 48 hours with a clinical diagnosis
of submandibular salivary gland haemangioma. He bled
spontaneously on the 25th and 29th postoperative days for
which he was readmitted.
He was then planned for a CT-angiography while an Inter-
ventional Radiologist was consulted for a possible selec-
tive embolisation; the facility however was not available.
Independent reviews by the Surgical Oncologist and the
Cardiovascular Surgeon were not suggestive of the likeli-
hood of a named vascular structure at the region in ques-
tion. However the swelling had become massive almost
compromising the airway, making neck exploration haz-
ardous. Preliminary histology of the initial specimen
revealed chronic inflammation with presence of thick
walled vessels suspicious of amyloid angiopathy for
which special stain with Congo red was done.
Radiotherapist review recommended haemostatic dose of
irradiation of 15GY in 3 fractions for a week. While await-
ing radiotherapy and final histologic diagnosis, he had a
fatal sudden and massive bleed, which defied all resusci-
tative measures. Histology confirmed amyloid angiopa-
thy. Figure 1 is a photomicrograph of the amyloid
angiopathy in the submandibular gland.
Discussion
Rudolph Virchow in 1854, because of his interest in this
disease which affected several body tissues and organs
causing them to become waxy looking and show reaction
with iodine and sulphuric acid, similar to that demon-
strated by corpora amylacea of nervous tissue, concluded
that the material did not have all the qualities of either
starch or cellulose, but that it was probably isomeric for
both. He then called it a name earlier used by botanists for
starch-like substances-amyloid. He was also the first to
describe vascular involvement of this disease.
The condition, however, that is known today as amy-
loidosis was first described by Rokitansky in 1842. It
remains one of the challenging diseases facing the clini-Page 2 of 4
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pathogenesis have remained elusive and speculative and
its management, controversial. To date, no single treat-
ment has been shown to alter the underlying pathology or
disease progression [5].
There have been several classifications of Amyloidosis by
different researchers [5,6]. Currently, "Amyloidologists"
classify amyloidosis based on its constituent chemical
fibrils into categories such as Light Chain Amyloidosis
(AL), Amyloid Associated Protein (AA) and Transthyretin
Amyloidosis (ATTR) and not based on clinical syndromes.
Because a given biochemical form of amyloid for exam-
ple, AA, may be associated with amyloid deposition in
diverse clinical settings, a clinical-biochemical classifica-
tion has been suggested [7].
On clinical grounds, the systemic or generalised pattern is
subclassified into primary and secondary. It is primary
systemic amyloidosis when associated with some immu-
nocyte dyscrasias. This is the most common form seen in
5–15% of multiple myeloma. The amyloid fibril protein
is AL. It is characterised by multiple osteolytic lesions in
the skeletal system. As our patient never presented with
bone pains or other skeletal symptoms, skeletal survey for
multiple myeloma was not done. However, one cannot
rule out that posibility, especially, if it was subclinical.
Furthermore, bone marrow biopsy was not done as the
suspicion was not strong enough, moreso that the urinary
Bence-Jones protein was negative. This appears an over-
sight for the very reason that serum Bence-Jones protein
was not done. However, clinical picture of a burning sen-
sation in the head and neck region indicating peripheral
nerve involvement, thickened skin and macroglossia are
some of the presentations of this form of amyloidosis
along with heart, kidney and gastrointestinal tract
involvement [8]. Secondary systemic amyloidosis is seen
in patients with destructive chronic inflammatory dis-
eases. The amyloid fibril proteins here are of the AA type,
suggesting that this form of amyloidosis is related to
recurrent bouts of inflammation that is also seen in hered-
ofamilial amyloidosis. The gene implicated in this type of
amyloidosis is called the Pyrin gene. It is responsible for
regulating inflammation via neutrophil inhibition. In
mutation of this gene, minor traumas unleash a vigorous
tissue damaging effect [9].
Amyloidosis is an uncommon disease with poor records
world wide. This was also observed in our departmental
records where this happened to be the only recorded his-
tologically confirmed case. This could have been respon-
sible for the initial delay in our diagnosis. In the USA,
there are 1,275–3,200 new cases of primary systemic amy-
loidosis annually. This may not be unconnected with their
level of awareness regarding the disease including that of
the technological advancement, which makes sophisti-
cated investigative tools easily accessible and affordable.
Generally, peak age incidence is in the fifties, as was in our
case, with a male: female ratio of 2:1 and no racial bias.
The disease is rapidly fatal within 1 – 3 years of diagnosis.
Diagnosis is mostly made at post mortem, from renal, car-
diac and central nervous system involvement. The 5-year
survival rate has been put at 20% [5,7,10].
Diagnosis of amyloidosis is anchored on high index of
suspicion with detailed clinical history, thorough physical
examination and comprehensive investigations either to
confirm or rule out the presence of the disease. The
haemogram of this patient showed a normal red cell
count and packed cell volume. Though the WBC was
within normal range, the differential showed a reversal of
the neutrophil and lymphocyte count ratio, with the
former lower than normal. This could be a technical or
observer error. The platelet count was lower than normal
and could have contributed to the bleeding or com-
pounded an already existing disease or a manifestation of
marrow failure seen in myelomatosis! The latter appears
not a possibility as the haemogram was normal while the
former could be an isolated finding.
Bone marrow biopsy, erythrocyte sedimentation rate,
serum electrophoresis for monoclonal immunoglobulin
light chains as well as electron microscopy, X-ray crystal-
lography and infra-red spectroscopy that demonstrates
the B-pleated sheet conformation, responsible for the
green birefringence, could have resolved this dilemma. A
Photomicrograph of submandibular gland showing a large thick walled arteryFigure 1
Photomicrograph of submandibular gland showing a large 
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point to note here is that a great majority of patients with
AL amyloid do not have the classic multiple myeloma or
any other overt B-cell neoplasm but virtually all have
monoclonal immunoglobulins or free light chain or both
in their serum, urine or both.
Another investigative tool of importance could have been
radionuclide scan using radiolabelled serum amyloid P-
component (SAP) [11,12]. Serum biochemistry was nor-
mal signifying satisfactory functional kidneys and FNAC
was misleading, confirming the limited role it plays in
investigating swellings.
Though Congo red staining result came out late it still
gave us a confirmation of the diagnosis which would go a
long way at improving our management protocol.
Conclusion
Amyloidosis, though a rare disease is not uncommon. The
need for a detailed and comprehensive patient evaluation
cannot be overemphasized. So also is the role of a high
index of suspicion in evaluating patients with head and
neck swellings.
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